Real-world data on outcomes using taxane, trastuzumab, and pertuzumab (THP) in patients with early stage HER2+breast cancer.
JOURNAL OF CLINICAL ONCOLOGY（2022）
关键词
breast cancer,trastuzumab,her2+,pertuzumab,real-world
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要